By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Biktarvy14.33B48.69%
Other3.54B12.02%
Descovy2.76B9.37%
Genvoya1.5B5.09%
Yescarta1.5B5.08%
Trodelvy1.4B4.75%
Sofosbuvir/Velpatasvir1.27B4.32%
Odefsey1.17B3.96%
Vemlidy1.07B3.63%
Veklury911M3.09%
View all
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States20.88B70.90%
Europe5.06B17.20%
Other international3.5B11.90%